Senior insider sale
AKTIS ONCOLOGY, INC. — senior position signals high conviction
$196.5K
7.92K shares
What this filing means
HERRMANN KEN plans to sell 7.92K shares of AKTIS ONCOLOGY, INC. valued at approximately $196.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/20/2026ACC: 0001950047-26-007234
7.92K
Shares to sell
$196.5K
Approx. market value
4.86K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/20/2026
4.86KTotal acquired4.86K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/20/2026 | Stock Option Exercise Cash | 4.86K | — |
| Total | 4.86K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.06K
Market value
$77.3K
7/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.86K
Market value
$119.3K
7/20/2026
Total
Units
7.92K
Value
$196.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/17/2026 | 3.06K | $77.3K | — | Completed |
| Planned — Approximate Date | ||||
7/20/2026 | 4.86K | $119.3K | NASDAQ | Planned |
| Total | 7.92K | $196.5K | ||